| Thomas Chaffee, MD | |
|
300 W 19th Ter, Kansas City, MO 64108-2026 | |
| (816) 404-5709 | |
| Not Available |
| Full Name | Thomas Chaffee |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 8 Years |
| Location | 300 W 19th Ter, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053767616 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 4301109262 (Michigan) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 2020021411 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Truman Medical Center Hospital Hill | Kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Health Physicians | 1153235825 | 301 |
| Truman Medical Center Incorporated | 7315841418 | 211 |
News Archive
Global well-being improvement leader Healthways announced today that it has been awarded a contract to provide Australia's largest health coaching program, Get Healthy Information and Coaching Service, in New South Wales, Tasmania, the Australian Capital Territory, Queensland and South Australia for the next three years.
Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
EpiCept Corporation today announced the Company has identified a statistically significant survival benefit in a subgroup of Acute Myeloid Leukemia patients in its previous Phase III trial with Ceplene administered with low-dose interleukin-2.
The Wall Street Journal reports that Judge J. Harvie Wilkinson said the high court should "think twice" about overturning the law. In other health law news, the White House's under-the-radar effort to build support for the overhaul appears to be working.
› Verified 4 days ago
| Entity Name | University Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669456257 PECOS PAC ID: 1153235825 Enrollment ID: O20031117000701 |
News Archive
Global well-being improvement leader Healthways announced today that it has been awarded a contract to provide Australia's largest health coaching program, Get Healthy Information and Coaching Service, in New South Wales, Tasmania, the Australian Capital Territory, Queensland and South Australia for the next three years.
Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
EpiCept Corporation today announced the Company has identified a statistically significant survival benefit in a subgroup of Acute Myeloid Leukemia patients in its previous Phase III trial with Ceplene administered with low-dose interleukin-2.
The Wall Street Journal reports that Judge J. Harvie Wilkinson said the high court should "think twice" about overturning the law. In other health law news, the White House's under-the-radar effort to build support for the overhaul appears to be working.
› Verified 4 days ago
| Entity Name | Truman Medical Center Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144207937 PECOS PAC ID: 7315841418 Enrollment ID: O20031120000847 |
News Archive
Global well-being improvement leader Healthways announced today that it has been awarded a contract to provide Australia's largest health coaching program, Get Healthy Information and Coaching Service, in New South Wales, Tasmania, the Australian Capital Territory, Queensland and South Australia for the next three years.
Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
EpiCept Corporation today announced the Company has identified a statistically significant survival benefit in a subgroup of Acute Myeloid Leukemia patients in its previous Phase III trial with Ceplene administered with low-dose interleukin-2.
The Wall Street Journal reports that Judge J. Harvie Wilkinson said the high court should "think twice" about overturning the law. In other health law news, the White House's under-the-radar effort to build support for the overhaul appears to be working.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Chaffee, MD 2310 Holmes St, Ste 800, Kansas City, MO 64108-2602 Ph: (816) 404-8188 | Thomas Chaffee, MD 300 W 19th Ter, Kansas City, MO 64108-2026 Ph: (816) 404-5709 |
News Archive
Global well-being improvement leader Healthways announced today that it has been awarded a contract to provide Australia's largest health coaching program, Get Healthy Information and Coaching Service, in New South Wales, Tasmania, the Australian Capital Territory, Queensland and South Australia for the next three years.
Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
EpiCept Corporation today announced the Company has identified a statistically significant survival benefit in a subgroup of Acute Myeloid Leukemia patients in its previous Phase III trial with Ceplene administered with low-dose interleukin-2.
The Wall Street Journal reports that Judge J. Harvie Wilkinson said the high court should "think twice" about overturning the law. In other health law news, the White House's under-the-radar effort to build support for the overhaul appears to be working.
› Verified 4 days ago
Dr. Irene E Bettinger, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4400 Broadway, Suite 520, Kansas City, MO 64111 Phone: 816-531-4080 Fax: 816-531-0281 | |
Parimal B Purohit, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3100 Ne 83rd St, Suite 1001, Kansas City, MO 64119 Phone: 816-468-0400 | |
Khursheed Zia, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 825 Euclid Ave, Kansas City, MO 64124 Phone: 816-474-4920 Fax: 816-474-4914 | |
Irfan Handoo, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1010 Carondelet Drive, Suite 329, Kansas City, MO 64114 Phone: 816-441-9875 | |
Kingsley U. Osuagwu, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 300 W 19th Ter, Kansas City, MO 64108 Phone: 816-404-5709 Fax: 816-404-5044 | |
Dr. Daniel V Spurlock, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 211 Ne 54th St, Suite 201, Kansas City, MO 64118 Phone: 816-453-6777 Fax: 816-464-3601 | |
Dr. Jay Gino Barone, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5534 Crestwood Dr, Kansas City, MO 64110 Phone: 816-361-9422 |